746 related articles for article (PubMed ID: 24985132)
1. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
Kwon-Chung KJ; Fraser JA; Doering TL; Wang Z; Janbon G; Idnurm A; Bahn YS
Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a019760. PubMed ID: 24985132
[TBL] [Abstract][Full Text] [Related]
2. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
mBio; 2012; 3(3):. PubMed ID: 22570277
[TBL] [Abstract][Full Text] [Related]
3. Etiological factors of cryptococcosis - what makes them pathogens ?
Dylag M
Med Dosw Mikrobiol; 2015; 67(3-4):221-31. PubMed ID: 27019916
[TBL] [Abstract][Full Text] [Related]
4. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Oliveira LSS; Pinto LM; de Medeiros MAP; Toffaletti DL; Tenor JL; Barros TF; Neves RP; Neto RGL; Milan EP; Padovan ACB; Rocha WPDS; Perfect JR; Chaves GM
Front Cell Infect Microbiol; 2021; 11():642658. PubMed ID: 34277464
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus gattii: a resurgent fungal pathogen.
Chaturvedi V; Chaturvedi S
Trends Microbiol; 2011 Nov; 19(11):564-71. PubMed ID: 21880492
[TBL] [Abstract][Full Text] [Related]
9. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
10. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
[TBL] [Abstract][Full Text] [Related]
11. Microevolution of Serial Clinical Isolates of
Chen Y; Farrer RA; Giamberardino C; Sakthikumar S; Jones A; Yang T; Tenor JL; Wagih O; Van Wyk M; Govender NP; Mitchell TG; Litvintseva AP; Cuomo CA; Perfect JR
mBio; 2017 Mar; 8(2):. PubMed ID: 28270580
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting analysis for identification of the Cryptococcus neoformans-Cryptococcus gattii complex.
Gago S; Zaragoza Ó; Cuesta I; Rodríguez-Tudela JL; Cuenca-Estrella M; Buitrago MJ
J Clin Microbiol; 2011 Oct; 49(10):3663-6. PubMed ID: 21832024
[TBL] [Abstract][Full Text] [Related]
13. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
15. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
16. The Cryptococcus gattii species complex: Unique pathogenic yeasts with understudied virulence mechanisms.
Saidykhan L; Onyishi CU; May RC
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010916. PubMed ID: 36520688
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans variety gattii.
Sorrell TC
Med Mycol; 2001 Apr; 39(2):155-68. PubMed ID: 11346263
[TBL] [Abstract][Full Text] [Related]
18. The triple threat of cryptococcosis: it's the body site, the strain, and/or the host.
Perfect JR
mBio; 2012; 3(4):. PubMed ID: 22782526
[TBL] [Abstract][Full Text] [Related]
19. [CAP59 gene amplification in Cryptococcus neoformans and Cryptococcus gattii directly from a yeast suspension].
Siachoque N; Jewtuchowicz VM; Iovannitti C; Mujica MT
Rev Argent Microbiol; 2010; 42(2):91-4. PubMed ID: 20589327
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Vitek MS for Differentiation of
Siqueira LPM; Gimenes VMF; de Freitas RS; Melhem MSC; Bonfietti LX; da Silva AR; Souza Santos LB; Motta AL; Rossi F; Benard G; de Almeida JN
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30429250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
